Tetrazole NK1 receptor antagonists: The identification of an exceptionally potent orally active antiemetic compound
- 7 May 1996
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 6 (9) , 1015-1020
- https://doi.org/10.1016/0960-894x(96)00163-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The pharmacology of GR203040, a novel, potent and selective non‐peptide tachykinin NK1 receptor antagonistBritish Journal of Pharmacology, 1995
- The broad‐spectrum anti‐emetic activity of the novel non‐peptide tachykinin NK1 receptor antagonist GR203040British Journal of Pharmacology, 1995
- Discovery of an Orally Bioavailable NK1 Receptor Antagonist, (2S,3S)-(2-Methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (GR203040), with Potent Antiemetic ActivityJournal of Medicinal Chemistry, 1995
- Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferretsEuropean Journal of Pharmacology, 1993
- One-pot synthesis of trifluoroacetimidoyl halidesThe Journal of Organic Chemistry, 1993
- The Conversion of Secondary Amides to Tetrazoles with Trifluoromethanesulfonic Anhydride and Sodium AzideSynthesis, 1993
- Discovery of a potent substance P antagonist: recognition of the key molecular determinantJournal of Medicinal Chemistry, 1992
- Muscarinic receptor binding profile of para-substituted caramiphen analogsJournal of Medicinal Chemistry, 1991